| Jariwala, Sunit |
NCT03694158: Investigating Dupilumab's Effect in Asthma by Genotype |
|
|
| Recruiting | 4 | 150 | US | Dupilumab, Dupixent®, Placebo | Boston Children's Hospital, National Institute of Allergy and Infectious Diseases (NIAID), Regeneron Pharmaceuticals, HealthBeacon Plc, Merck Sharp & Dohme LLC, Sanofi | Asthma | 09/26 | 03/27 | | |
NCT03847142: An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care |
|
|
| Completed | N/A | 110 | US | ASTHMAXcel mobile application, Outpatient primary care | Montefiore Medical Center | Asthma | 05/23 | 05/23 | | |
| Completed | N/A | 80 | US | ASTHMAXcel App | Montefiore Medical Center | Asthma | 07/23 | 07/23 | | |
NCT04810260: Implementing, a Mobile Health Application for HIV Infected and Uninfected Women With Co-morbidities in the Outpatient Setting |
|
|
| Completed | N/A | 42 | US | Use mobile health app (WellXcel) to increase knowledge | Montefiore Medical Center | Mobile Health, Asthma, Diabetes Mellitus | 07/23 | 07/23 | | |
NCT05850390: Real-time Remote Asthma Monitoring Through Smartphone Voice Analysis |
|
|
| Active, not recruiting | N/A | 84 | US | Respiratory-Responsive Vocal Biomarker application | Sonde Health, Montefiore Medical Center | Asthma | 11/23 | 11/23 | | |
| Hereford, Sherae |
NCT03694158: Investigating Dupilumab's Effect in Asthma by Genotype |
|
|
| Recruiting | 4 | 150 | US | Dupilumab, Dupixent®, Placebo | Boston Children's Hospital, National Institute of Allergy and Infectious Diseases (NIAID), Regeneron Pharmaceuticals, HealthBeacon Plc, Merck Sharp & Dohme LLC, Sanofi | Asthma | 09/26 | 03/27 | | |
TETON, NCT04708782: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis |
|
|
| Recruiting | 3 | 576 | Canada, US | Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer | United Therapeutics | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | 06/25 | 06/25 | | |
|
|
NCT06004440: Real World Registry for Use of the Ion Endoluminal System |
|
|
| Recruiting | N/A | 3000 | US | Ion Endoluminal System | Intuitive Surgical | Lung Cancer, Multiple Pulmonary Nodules, Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site, Neoplasms, Lung Diseases, Respiratory Tract Diseases | 08/26 | 08/27 | | |
| Green, Samuel |
NCT03694158: Investigating Dupilumab's Effect in Asthma by Genotype |
|
|
| Recruiting | 4 | 150 | US | Dupilumab, Dupixent®, Placebo | Boston Children's Hospital, National Institute of Allergy and Infectious Diseases (NIAID), Regeneron Pharmaceuticals, HealthBeacon Plc, Merck Sharp & Dohme LLC, Sanofi | Asthma | 09/26 | 03/27 | | |
| McLaurin, Yvette |
NCT03694158: Investigating Dupilumab's Effect in Asthma by Genotype |
|
|
| Recruiting | 4 | 150 | US | Dupilumab, Dupixent®, Placebo | Boston Children's Hospital, National Institute of Allergy and Infectious Diseases (NIAID), Regeneron Pharmaceuticals, HealthBeacon Plc, Merck Sharp & Dohme LLC, Sanofi | Asthma | 09/26 | 03/27 | | |
| Burdzinski, Gabrielle |
NCT03694158: Investigating Dupilumab's Effect in Asthma by Genotype |
|
|
| Recruiting | 4 | 150 | US | Dupilumab, Dupixent®, Placebo | Boston Children's Hospital, National Institute of Allergy and Infectious Diseases (NIAID), Regeneron Pharmaceuticals, HealthBeacon Plc, Merck Sharp & Dohme LLC, Sanofi | Asthma | 09/26 | 03/27 | | |
